Search results
Brian S. Hartley. Sir Gregory Paul Winter CBE FRS FMedSci (born 14 April 1951) [ 6][ 7] is a Nobel Prize -winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein ...
May 24, 2024 · Delve into the remarkable journey of Sir Gregory Winter, where revolutionary science and entrepreneurial tenacity collide, promising an inspiring tale that has led to a paradigm shift in the pharmaceutical landscape.
Nov 8, 2019 · Medicinal chemist and Nobel Prize winner Sir Gregory Winter CBE has received a Doctor of Medical Science (honoris causa) in recognition of his outstanding contribution to medical science, entrepreneurship and human health.
I also developed genetic engineering strategies for the design (1984–1988) and evolution (1988– 1997) of antibody pharmaceuticals suitable for treatment of cancer and immune disorders, helping to spearhead the development of antibodies as a new class of powerful biologics.
Gregory P. Winter (born April 14, 1951, Leicester, England) is a British biochemist known for his development of the first humanized antibodies, his research on the directed evolution of antibodies, and his application of phage display technology for the development of fully human therapeutic antibodies.
- Kara Rogers
Sir Gregory P. Winter. The Nobel Prize in Chemistry 2018. Born: 14 April 1951, Leicester, United Kingdom. Affiliation at the time of the award: MRC Laboratory of Molecular Biology, Cambridge, United Kingdom. Prize motivation: “for the phage display of peptides and antibodies” Prize share: 1/4. Life.
Oct 3, 2018 · “I think it’s truly important that scientists don't ignore the opportunities that may come from their work.” Throughout his career as a scientist, Sir Gregor...
- 7 min
- 4.9K
- Nobel Prize
